Erratum to Prevalence and clinical significance of pathogenic germline BRCA1/2 mutations in Chinese non-small cell lung cancer patients.
Hu X, Yang D, Li Y, Li L, Wang Y, Chen P, Xu S, Pu X, Zhu W, Deng P, Ye J, Zhang H, Lizaso A, Liu H, Mao X, Huang H, Chu Q, Hu C.
Hu X, et al. Among authors: deng p.
Cancer Biol Med. 2020 May 15;17(2):513. doi: 10.20892/j.issn.2095-3941.2020.0029.
Cancer Biol Med. 2020.
PMID: 32587786
Free PMC article.
No abstract available.